Deep Health AI India acquires 5.98% stake in Exxaro Tiles Ltd

What the filing disclosed

On 25 June 2026, Exxaro Tiles Ltd (BSE: 543327) received a Regulation 29(2) disclosure from the Securities and Exchange Board of India (SEBI) on behalf of Deep Health AI India Limited (formerly Deep Diamond India Ltd). The filing records the shareholder’s open‑market acquisition and disposal of Exxaro Tiles equity shares between 26 February 2026 and 22 June 2026. After completing the transactions, Deep Health AI’s shareholding stood at 5.98% of the target’s total issued and paid‑up equity capital.

Acquisition and disposal details

• Shares acquired: 50,38,402 shares, equivalent to 1.13% of Exxaro Tiles’ total share capital.
• Shares sold: 15,13,3573 shares, equivalent to 3.38% of the total.
• Net change: A net increase of 35,25,029 shares, raising the shareholder’s stake from 3.23% to 5.98%.
• Mode of transaction: Open‑market purchases and sales executed through the stock‑exchange mechanism.
• Transaction window: 26 Feb 2026 – 22 Jun 2026.

The filing confirms that none of the shares were pledged, encumbered, or subject to any voting‑right arrangements other than the ordinary equity rights. No warrants, convertible securities, or other instruments were involved.

Shareholding before and after the transactions

The reduction in the absolute number of shares held (from 3.68 crore to 2.67 crore) reflects the net effect of the disposal of a larger block of shares than was purchased. Despite the reduction in absolute shares, the filing reports the final holding as 5.98% of the total issued and paid‑up equity, indicating that the overall share base of Exxaro Tiles remained unchanged during the period.

Key facts at a glance

The disclosure satisfies SEBI’s Regulation 29(2) requirement to inform the market of any change in shareholding that crosses the 1% threshold.

Why this matters for investors

The filing is a statutory compliance document rather than a corporate announcement of a strategic partnership or merger. Nonetheless, it provides investors with transparent information about a material change in the ownership structure of Exxaro Tiles. A 5.98% stake, while still below the 10% trigger for mandatory open‑offer obligations under SEBI’s takeover code, is sizable enough to warrant monitoring. The shareholder is not part of the promoter group, which means the stake does not automatically translate into board representation, but it could influence voting outcomes on ordinary resolutions, especially in a company with a dispersed shareholding pattern.

From a dilution perspective, the equity share capital of Exxaro Tiles remained unchanged; the transaction was purely a secondary market trade. Consequently, there is no immediate impact on earnings per share or capital structure. However, the open‑market nature of the trade signals that the shares were bought and sold at prevailing market prices, providing a market‑based indication of demand for Exxaro Tiles stock during the February‑June window.

Regulatory compliance is also a key consideration. By filing under Regulation 29(2), Deep Health AI ensures that the market is aware of its holdings, thereby avoiding any breach of insider‑trading or takeover‑code provisions. The disclosure also serves as a reference point for any future increase in stake that might trigger a mandatory open offer.

Conclusion

The SEBI‑mandated disclosure filed on 25 June 2026 records Deep Health AI India Ltd’s net acquisition of a 5.98% stake in Exxaro Tiles Ltd through open‑market transactions conducted between 26 February and 22 June 2026. While the shareholding increase does not cross the 10% threshold that would require a formal takeover offer, it represents a material position that investors should track for potential voting influence. No further corporate actions, such as board appointments or capital restructuring, are indicated in the filing, and the company’s equity capital remains unchanged.